Rua Bioscience Limited (NZE:RUA)

New Zealand flag New Zealand · Delayed Price · Currency is NZD
0.0250
0.00 (0.00%)
Apr 24, 2025, 3:27 PM NZST
-57.77%
Market Cap 5.59M
Revenue (ttm) 1.06M
Net Income (ttm) -4.67M
Shares Out 223.65M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 54,104
Average Volume 98,345
Open 0.0250
Previous Close 0.0250
Day's Range 0.0250 - 0.0250
52-Week Range 0.0230 - 0.0800
Beta 0.27
RSI 38.93
Earnings Date May 27, 2025

About Rua Bioscience

Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. The company offers cannabinoid derived medicines. It is also involved in seed production and genetic discovery related activities. In addition, the company engages in plant breeding business, as well as involved in plant research activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founde... [Read more]

Sector Healthcare
Founded 2016
Country New Zealand
Stock Exchange New Zealand Stock Exchange
Ticker Symbol RUA
Full Company Profile

Financial Performance

In 2024, Rua Bioscience's revenue was 316,350, a decrease of -52.68% compared to the previous year's 668,484. Losses were -13.72 million, 130.2% more than in 2023.

Financial Statements

News

There is no news available yet.